Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Homologous Recombination Deficiency and Response to Olaparib in Patients With Recurrent Epithelial Ovarian Cancer (EOC)

NCT04780945 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT04780945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04780945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Homologous Recombination Deficiency and Response to Olaparib in Patients With Recurrent Epithelial Ovarian Cancer (EOC)
Lead sponsor
Leiden University Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
January 21, 2019
Completion date
December 31, 2024
Enrollment
27 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, homologous recombination deficiency, ovarian neoplasm epithelial